Medical Condition News

RSS

Healthcare announces important changes to the U.S. product label for Optison

GE Healthcare today announced important changes to the U.S. product label for Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a contrast agent that may improve the visualization of the left ventricular border - an area of the heart that is critical to see in order to diagnose certain heart diseases such as hypertrophic cardiomyopathy.

22 Aug 2012

GM-CSF depletion suppresses pain in people with arthritis-related conditions

The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation.

22 Aug 2012

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has initiated dosing in a multicenter (USA), randomized, placebo and active comparator controlled Phase 2b study that will enroll approximately 600 patients with type 2 diabetes (hemoglobin A1c 7% - 11%) inadequately controlled with diet and exercise, metformin, a sulfonylurea or a combination of metformin/sulfonylurea.

22 Aug 2012

Wockhardt receives final FDA approval for Felodipine ANDA to treat hypertension

Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing extended-release tablets containing 2.5mg, 5mg and 10mg Felodipine, which are used in treating hypertension.

22 Aug 2012

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

Investigators at Nationwide Children's Hospital may have discovered a biological explanation for why low levels of oxygen advance spinal muscular atrophy (SMA) symptoms and why breathing treatments help SMA patients live longer. The findings appear in Human Molecular Genetics.

22 Aug 2012

Study highlights Nek9 protein as decisive factor in cell division

A study by the Institute for Research in Biomedicine (IRB Barcelona) and the Center for Genomic Regulation (acronym in Catalan CRG) highlights the protein Nek9 as a decisive factor in cell division, a fundamental process for both the development of an organism and tissue maintenance.

22 Aug 2012

FDA clears Covalon’s SurgiClear antimicrobial silicone adhesive film dressing

Covalon Technologies Ltd., an advanced medical technologies company, today announced United States Food and Drug Administration ("FDA") clearance of SurgiClear antimicrobial silicone adhesive film dressing designed to cover and protect wound sites and wound closure devices, as well as secure other primary dressings to a patient's skin.

22 Aug 2012

Roundup: Texas insurance regulator pulls out-of-network notice rules; Bay-Area Komen fundraising suffers after flap; Mass.'s Steward pushing to buy Maine hospital

Texas' top insurance regulator has rescinded new rules designed to help consumers avoid a common pitfall when they seek medical treatment -- big bills for out-of-network care -- a move that angers consumer advocates and doctors groups. The rules were meant to give more than 4 million Texans covered by preferred provider organization health plans, or PPOs, more information about whether they'd pay the higher out-of-network costs if they were hospitalized and seen by a specialist.

22 Aug 2012

Eco-friendly blood glucose monitor developed by Cambridge Consultants

A blood glucose monitor concept for diabetics that’s simpler to use, less cumbersome to carry and has a third of the environmental impact of traditional devices has been developed by Cambridge Consultants.

21 Aug 2012

GWCI announces new collaboration with National Institutes of Health Federal Credit Union

The National Institutes of Health Federal Credit Union, one of the largest credit unions in the Washington, D.C. metropolitan area and the nation's largest serving the healthcare and biomedical industries has proudly announced a new collaboration with the George Washington Cancer Institute (GWCI).

21 Aug 2012

New silicon chips help identify patients with lupus

Researchers at the Stanford University School of Medicine and Intel Corp. have collaborated to synthesize and study a grid-like array of short pieces of a disease-associated protein on silicon chips normally used in computer microprocessors.

21 Aug 2012

Bile duct cancer chosen as next indication for PCI Biotech

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech’s proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.

21 Aug 2012

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

Seattle-based biotech company Kineta, Inc. announced today it has received regulatory clearance in the Netherlands to initiate a first-in-human trial of ShK-186, an autoimmune drug candidate that specifically inhibits the Kv1.3 potassium ion channel.

21 Aug 2012

UCLA Medical Center receives platinum award for outstanding heart attack care

Ronald Reagan UCLA Medical Center has received an award for outstanding heart attack care from the American College of Cardiology Foundation called the NCDR ACTION Registry-GWTG Platinum Performance Achievement Award for 2012.

21 Aug 2012

House Bill 6218 would create interdepartmental autoimmune disease coordinating committee

Autoimmune disease patients received a win recently when U.S. Rep. Ann Marie Buerkle (R-NY) introduced House Bill 6218 to Congress. The bill would create an interdepartmental autoimmune disease coordinating committee.

21 Aug 2012

DPT Labs, Imprimis sign agreement to commence work on Impracor clinical supplies

Imprimis Pharmaceuticals, Inc., a specialty pharmaceutical company developing non-invasive, topically delivered products, announced that it has signed an agreement with DPT Labs to commence work on supplying Imprimis with quantities of its active topical anti-inflammatory drug, Impracor, for currently planned Phase 3 clinical trials.

21 Aug 2012

Berry wines may help people with diabetes decrease their blood sugar

In evaluating the bioactive compounds of Illinois blueberry and blackberry wines, University of Illinois scientists have found compounds that inhibit enzymes responsible for carbohydrate absorption and assimilation. And that could mean a tasty way to help people with diabetes decrease their blood sugar.

21 Aug 2012

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

21 Aug 2012

Study: Medicare 'donut hole' not linked to more heart attacks, related deaths

U.S. seniors forced to pay full price for their medications while in Medicare's so-called donut hole didn't suffer more heart attacks or deaths as a result, in a new study.

21 Aug 2012

New tool reveals surprising clues about how cancer cells respond to therapy

A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments.

21 Aug 2012

Medical Condition News

Healthcare announces important changes to the U.S. product label for Optison

GM-CSF depletion suppresses pain in people with arthritis-related conditions

PhaseBio commences Glymera Phase 2b study in type 2 diabetes

Wockhardt receives final FDA approval for Felodipine ANDA to treat hypertension

Investigators discover biological explanation for why low levels of oxygen advance SMA symptoms

Study highlights Nek9 protein as decisive factor in cell division

FDA clears Covalon’s SurgiClear antimicrobial silicone adhesive film dressing

Roundup: Texas insurance regulator pulls out-of-network notice rules; Bay-Area Komen fundraising suffers after flap; Mass.'s Steward pushing to buy Maine hospital

Eco-friendly blood glucose monitor developed by Cambridge Consultants

GWCI announces new collaboration with National Institutes of Health Federal Credit Union

New silicon chips help identify patients with lupus

Bile duct cancer chosen as next indication for PCI Biotech

Kineta receives regulatory clearance to commence ShK-186 Phase I trial in autoimmune disease

UCLA Medical Center receives platinum award for outstanding heart attack care

House Bill 6218 would create interdepartmental autoimmune disease coordinating committee

DPT Labs, Imprimis sign agreement to commence work on Impracor clinical supplies

Berry wines may help people with diabetes decrease their blood sugar

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Study: Medicare 'donut hole' not linked to more heart attacks, related deaths

New tool reveals surprising clues about how cancer cells respond to therapy

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News